Der neueste Peer-reviewed Artikel


    Nature Communications 8, Article number: 198 (2017)
    Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signatures.
    Khan FM, Marquardt S, Gupta SK, Knoll S, Schmitz U, Spitschak A, Engelmann D, Vera J, Wolkenhauer O, Pützer BM.

Der neueste Buchartikel


    Regenerative Medicine, Chapter 19, 2nd ed. 2013 (31. Januar 2013). G. Steinhoff. Textbook Regenerative Medicine – From Protocol to Patient. Springer-Verlag GmbH ISBN-10: 9400756895 ISBN-13: 9789400756892
    Vector technology and cell targeting: Peptide-tagged adenoviral vectors as a powerful tool for cell specific targeting.
    Reetz J, Herchenröder O, Schmidt A, Pützer BM.

Der neueste Abstract


    JEADV 2017; 31:61-62.
    Melanoma-associated hypopigmentation as sign of EMT-propelled metastatic spread: towards identification of the molecular particularities.
    Fürst K, Steder, M, Logotheti, S, Marquardt, S, Engelmann D, Pützer, BM.

Die neueste Abschlussarbeit


    Ferdinand Fenner (Arzt)
    Der Transkriptionsfaktor E2F1 in Peniskarzinomzellen
    Rostock 

... weitere Publikationen


    Trends Mol Med. 2006; 12:177-185.
    E2F1-related apoptosis: turning killers into therapeutics.
    Stanelle J, Pützer BM.
    J Cell Mol Med. 2008; 12(6A):2427-2438.
    Spliceosomal protein E regulates neoplastic cell growth by modulating expression of cyclin E/CDK2 and G2/M checkpoint proteins.
    Li Z, Pützer BM.
    Int J Cancer. 2016 Apr 1;138(7):1792-801.
    Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation.
    Casalegno-Garduño R, Schmitt A, Spitschak A, Greiner J, Wang L, Hilgendorf I, Hirt C, Ho AD, Freund M, Schmitt M.